You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0690 Clinical experience with infliximab biosimilar (BOW015) in ankylosing spondylitis- efficacy and safety analysis from an indian perspective

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0690 Clinical experience with infliximab biosimilar (BOW015) in ankylosing spondylitis- efficacy and safety analysis from an indian perspective
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20175901
Jul 20173403
Aug 20171800
Sep 20171400
Oct 20173003
Nov 20171001
Dec 20172601
Jan 20183002
Feb 20181000
Mar 20181801
Apr 20183001
May 20181001
Jun 20181600
Jul 20182200
Aug 2018400
Sep 20181801
Oct 2018400
Nov 2018201
Dec 2018402
Jan 2019202
Feb 2019403
Mar 2019002
Apr 2019203
May 2019203
Jun 2019202
Jul 2019202
Aug 2019604
Sep 2019101
Oct 2019305
Nov 2019202
Dec 2019602
Jan 2020202
Feb 2020200
Mar 2020402
Apr 2020002
May 2020402
Jun 2020801
Jul 2020602
Aug 2020601
Sep 20202001
Oct 2020802
Nov 2020602
Dec 2020800
Jan 2021002
Feb 2021001
Mar 2021001
Apr 2021401
May 2021001
Jun 2021001
Jul 2021004
Aug 2021004
Sep 2021003
Oct 20210011
Nov 20215013
Dec 20211402
Jan 2022201
Feb 2022201
Mar 2022001
Apr 20221600
May 20221608
Jun 20222603
Jul 20221002
Aug 20221008
Sep 2022206
Oct 2022403
Nov 2022801
Dec 2022402
Jan 2023201
Feb 2023801
Mar 20233000
Apr 20231201
May 20232003
Jun 2023600
Jul 2023204
Aug 2023402
Sep 2023400
Oct 2023601
Nov 2023401
Dec 20231601
Jan 2024400
Feb 20241601
Mar 202410043
Total7320205